Winthrop Partners WNY LLC Takes $923,000 Position in Danaher Corporation $DHR

Posted by Geri Gentry on Jun 20th, 2026

Winthrop Partners WNY LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 4,032 shares of the conglomerate’s stock, valued at approximately $923,000.

Several other institutional investors have also recently made changes to their positions in DHR. Bank Pictet & Cie Europe AG lifted its position in Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after purchasing an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd bought a new stake in shares of Danaher in the 3rd quarter worth about $3,251,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after buying an additional 186,584 shares in the last quarter. Defender Capital LLC. bought a new position in shares of Danaher in the 4th quarter valued at about $35,715,000. Finally, CIBC Bancorp USA Inc. bought a new position in shares of Danaher in the 3rd quarter valued at about $17,480,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $177.74 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a 50 day moving average price of $179.62 and a 200-day moving average price of $203.07. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The stock has a market capitalization of $125.80 billion, a PE ratio of 34.38, a PEG ratio of 2.26 and a beta of 0.81.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the company earned $1.88 earnings per share. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s payout ratio is 30.95%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of recent research reports. Guggenheim dropped their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Argus lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. HSBC dropped their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday, June 3rd. Barclays reduced their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a report on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

View Our Latest Stock Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.